In the present study, we showed that NUP107 is positively correlated with PD‐L1 and Tim‐3, which suggests that the therapeutic effect of ICIs in HCC patients may be enhanced by targeting NUP107. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.